Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of March 14 Dividend Increases/Decreases for the Week of March 7 Dividend Increases/Decreases for the Week of February 28 Dividend Increases/Decreases for the Week of February 21 Dividend Increases/Decreases for the Week of February 14

Results 151 - 160 of 201 for hum. (0.33 seconds) Alexion’s Executive Departures and an Update from Regeneron Pharma Image shown above: Performance of Regeneron since the... Nelson: The 16 Most Important Steps To Understand The Stock Market Image Source: Tim Green. We outline the... Stock-Selection Methodology, the Valuentum Buying Index Image Shown: The size of the circles generally... A Review of Johnson and Johnson’s Pharmaceutical Division Image Source: J&J. Let’s take a deep dive... Coca-Cola, Pepsi, Kimberly-Clark: Great Businesses But Lofty Earnings Multiples and Net Debt Positions We love the business models of some of the most... BioMarin Pharmaceuticals: A Rare Drug Powerhouse Image shown: BioMarin's stock price has had a choppy ride... Our Bullish Thesis on Gilead Sciences Image Source: Gilead. We have become enamored with... The US Dollar, GDP Expansion, and Earnings Investors wouldn’t think news flow is that robust... Updating Our Thoughts on Celgene Image Source: Celgene. Although the combination of... AbbVie’s Product Concentration Risk Intensifies; Shares Yield ~3.9% AbbVie will not seek accelerated approval for what had... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next